Browsing by Author "ARTEAGA, E"

Now showing 1 - 9 of 9
  • Thumbnail Image
    Item
    A PREPUBERTAL SURGE OF THYROTROPIN PRECEDES AN INCREASE IN THYROXINE AND 3,5,3'-TRIIODOTHYRONINE IN NORMAL-CHILDREN
    (ENDOCRINE SOC, 1991) MICHAUD, P; FORADORI, A; RODRIGUEZPORTALES, JA; ARTEAGA, E; LOPEZ, JM; TELLEZ, R
    The variations in plasma levels of TSH, T4, T3, and rT3, during the pubertal period, were studied in 647 school students from the urban area of Santiago in Chile (47% males and 53% females) with ages ranging between 7.5 and 15 yr. The subjects were grouped by age in consecutive intervals of 6 months each, and pubertal development was determined in every subject. TSH showed a significant increase, reaching a peak in the 9- to 9.5-yr interval. The same was found for T3 and T4, which reached a peak by 10 and 11 yr. The T4/T3 ratio did not show any significant variation with age. After 9.5 yr, a decrease in rT3 and increase in the T4/rT3 ratio was found. The TSH peak preceded the onset of clinical pubertal development, while the T3 and T4 peaks coincided with this onset. The variations in rT3 suggest an increase of peripheral conversion of T4 to T3. These transient events, not described until now, could be termed thyroidarche and could have a significant effect on pubertal growth and development.
  • No Thumbnail Available
    Item
    ADRENAL MACROTUMORS DIAGNOSED BY COMPUTED-TOMOGRAPHY
    (1990) LOPEZ, JM; FARDELLA, C; ARTEAGA, E; MICHAUD, P; RODRIGUEZ, JA; CRUZ, F
    Adrenal tumors larger than 6 cm are unusual but show a greater incidence of malignant etiologies than smaller adrenal tumors. The scarce information about adrenal macrotumors (AMT) induced us to study prospectively all patients who were seen in our clinic during the period 1984-1988 and were diagnosed by computed tomography (CT) to have an adrenal mass .gtoreq.6 cm. The clinical characteristics, including the main complaint, tumoral secretory activity, CT findings and histologic diagnosis from 18 patients are described; they represented a 0.3% of the total amount of abdominal CT studies performed. Seventy-two % of AMT resulted to be non cortisol or catecholamines secreting masses, and from them, a 38% corresponded to malignant etiologies characterized by marked and rapid weight loss. Four out of five hormone secreting AMT corresponded to pheochromocytomas, while the fifth one resulted to be a bilateral macronodular hyperplasia secreting cortisol. In two cases AMT did not correspond to a genuine adrenal mass, resulting to be a malignant histocytoma in one case and a hydatidic cyst in other one. When performed in two occasions, a percutaneous needle biopsy was a valuable diagnostic tool, permitting to diagnose a lymphoma and a tuberculoma. In conclusion: 1) AMT correspond mainly to non cortisol or catecholamines secreting tumors, often malignant; 2) not all AMT diagnosed by CT correspond to true adrenal masses; 3) percutaneous needle biopsy can be a helpful procedure for diagnosing nonfunctioning solid AMT.
  • No Thumbnail Available
    Item
    CONGENITAL 11-BETA-HYDROXYSTEROID DEHYDROGENASE-DEFICIENCY ASSOCIATED WITH JUVENILE HYPERTENSION - CORTICOSTEROID METABOLITE PROFILES OF 4 PATIENTS AND THEIR FAMILIES
    (1985) SHACKLETON, CHL; RODRIGUEZ, J; ARTEAGA, E; LOPEZ, JM; WINTER, JSD
    Four children with 11 .beta.-hydroxysteroid dehydrogenase deficiency are described. All patients had severe hypertension, hypokalemia, and low plasma aldosterone and renin activities. Two of the patients were siblings and 2 were unrelated. The most noticable biochemical feature of these individuals was the extremely low excretion of cortisol metabolites containing on 11-carbonyl group compared to the excretion of the 11 .beta.-hydroxyl containing metabolites. Although this condition is readily diagnosed in affected individuals by urinary steroid analysis, carriers of the defect do not differ from normal in their urinary steroids. Both parents of the affected siblings had normal 11-oxo-steroid/11 .beta.-hydroxysteroid ratios under baseline conditions and the lesions could not be revealed by ACTH administration.
  • No Thumbnail Available
    Item
    EFFECT OF ORAL POTASSIUM SUPPLEMENTS ON URINARY KALLIKREIN EXCRETION IN SHEEHANS SYNDROME
    (1988) LOPEZ, JM; MAHANA, D; RODRIGUEZ, JA; MICHAUD, P; ARTEAGA, E; FARDELLA, C
  • No Thumbnail Available
    Item
    EFFECT OF THE COMBINATION OF DEXAMETHASONE AND SODIUM IPODATE ON SERUM THYROID-HORMONES IN GRAVES-DISEASE
    (1983) ARTEAGA, E; LOPEZ, JM; RODRIGUEZ, JA; MICHAUD, P; LOPEZ, G
    To investigate the effect of the combination of dexamethasone (Dex) and sodium ipodate (SI) on hyperthyroidism, 24 patients with typical Graves'' disease, divided into 4 groups of 6 persons each were studied. Three groups (Study I) were studied acutely (24 h) to determine the effects of Dex (5 mg every 12 h i.m.), SI (1 oral dose of 3 g) and both drugs at the same doses, upon T4, T3 and rT3 [thyroxine, triidothyronine and reverse triiodothyronine] at 0900 h before therapy was started and 24 h later. The group on Dex and that on SI had a similar T3 decrement of 25.9 .+-. 4.0% and 35.8 .+-. 5.0%, respectively, (P < 0.05), whereas the effect of both drugs combined was greater (64.2 .+-. 3.6%; P < 0.01, Dex, and P < 0.01, SI, respectively). The increment of rT3 was markedly greater in those patients on SI than in those on Dex (561 .+-. 149.2% and 58.9 .+-. 11%, respectively, P < 0.025). A 4th group (Study II) was studied for 7 days while receiving both Dex (1 mg orally 3 times per day) and SI (500 mg orally 3 times per day). Both T4 (from 18.8 .+-. 1.1 to 13.1 .+-. 1.1 .mu.g/dl, P < 0.02) and T3 (from 593 .+-. 41 to 136.3 .+-. 12.7 ng/dl, P < 0.001) decreased at day 8. The initial brisk increment of rT3 at 24 h (808 .+-. 149%, P < 0.005) then diminished concomitantly with the fall of its precursor, T4. The pulse rate correlated with plasma T3 concentration (r = 0.67, P < 0.001) and varied from 104.7 .+-. 3.9 on day 1 to 77.3 .+-. 3.0 beats/min (P < 0.001) on day 4 and then remained stable. Dex and SI have potent inhibitory effects at the level of peripheral conversion of T4 and on the thyroid gland itself and the combined use of these drugs significantly increases these effects. Considering the rapid clinical improvement of thyrotoxicosis achieved with both drugs, this regimen may be valuable in the initial treatment of some patients.
  • No Thumbnail Available
    Item
  • No Thumbnail Available
    Item
  • No Thumbnail Available
    Item
    THE PARADOXICAL RESPONSE OF GROWTH-HORMONE (GH) TO THYROTROPIN-RELEASING-HORMONE (TRH) IN CONSTITUTIONALLY TALL CHILDREN INVOLVES A CHOLINERGIC PATHWAY
    (1989) ARTEAGA, E; VALENZUELAA, P; CATTANI, A; DELVALLE, M
    To investigate whether or not a cholinergic pathway is involved in the paradoxical response of GH to TRH in constitutionally tall children, we studied 8 healthy prepubertal children aged 42/12 - 7 10/12 yr, whose heights were over the 95th percentile of the NCHS tables. We defined as "paradoxical" a GH increment greater than 5 ng/ml in response to TRH. Five out of 8 children showed a paradoxical response of GH to TRH (mean GH peak after TRH of 10.7 .+-. 1.1 ng/ml). Pretreatment with atropine (0.01 mg/kg IM 30 min prior to the TRH administration) abolished the TRH induced GH rise (peak GH after TRH of 1.5 .+-. 1.0 ng/ml, p < 0.01) but did not modify the TSH response (peak TSH after TRH: basal conditions 8.7 .+-. 0.8 .mu.U/ml, post atropine: 9.5 .+-. 1.4 .mu.U/ml, p > 0.05). Our results demonstrate that a cholinergic pathway is involved in the paradoxical response of GH to TRH in constitutionally tall children.
  • No Thumbnail Available
    Item